Report Detail

Request for Sample of this report

Food & Beverages Global Sialylated Human Milk Oligosaccharides (HMO) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4583311
    • |
  • 29 March, 2024
    • |
  • Global
    • |
  • 99 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Food & Beverages

According to our (Global Info Research) latest study, the global Sialylated Human Milk Oligosaccharides (HMO) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Sialylated HMOs are an important type of HMOs, accounting for approximately 13% of total HMOs. 3’-Sialyllactose (3’-SL) and 6′-sialyllactose (6’-SL) are two simplest sialylated HMOs. The global market for Human Milk Oligosaccharides (HMO) was estimated to be worth US$ 467.7 million in 2023 and is forecast to a readjusted size of US$ 1227.5 million by 2030 with a CAGR of 14.5% during the forecast period 2024-2030.
The Global Info Research report includes an overview of the development of the Sialylated Human Milk Oligosaccharides (HMO) industry chain, the market status of Infant Formula (3'-Sialyllactose, 6'-Sialyllactose), Food (3'-Sialyllactose, 6'-Sialyllactose), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Sialylated Human Milk Oligosaccharides (HMO).
Regionally, the report analyzes the Sialylated Human Milk Oligosaccharides (HMO) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Sialylated Human Milk Oligosaccharides (HMO) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Sialylated Human Milk Oligosaccharides (HMO) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Sialylated Human Milk Oligosaccharides (HMO) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Tons), revenue generated, and market share of different by Type (e.g., 3'-Sialyllactose, 6'-Sialyllactose).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Sialylated Human Milk Oligosaccharides (HMO) market.
Regional Analysis: The report involves examining the Sialylated Human Milk Oligosaccharides (HMO) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Sialylated Human Milk Oligosaccharides (HMO) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Sialylated Human Milk Oligosaccharides (HMO):
Company Analysis: Report covers individual Sialylated Human Milk Oligosaccharides (HMO) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Sialylated Human Milk Oligosaccharides (HMO) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Infant Formula, Food).
Technology Analysis: Report covers specific technologies relevant to Sialylated Human Milk Oligosaccharides (HMO). It assesses the current state, advancements, and potential future developments in Sialylated Human Milk Oligosaccharides (HMO) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Sialylated Human Milk Oligosaccharides (HMO) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Sialylated Human Milk Oligosaccharides (HMO) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
3'-Sialyllactose
6'-Sialyllactose
Market segment by Application
Infant Formula
Food
Others
Major players covered
Chr. Hansen (Jennewein Biotechnologie GmgH)
DSM (Glycom A/S)
Inbiose
Kyowa Hakko Bio
GeneChem Inc.
FrieslandCampina Ingredients
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sialylated Human Milk Oligosaccharides (HMO) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Sialylated Human Milk Oligosaccharides (HMO), with price, sales, revenue and global market share of Sialylated Human Milk Oligosaccharides (HMO) from 2019 to 2024.
Chapter 3, the Sialylated Human Milk Oligosaccharides (HMO) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sialylated Human Milk Oligosaccharides (HMO) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Sialylated Human Milk Oligosaccharides (HMO) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Sialylated Human Milk Oligosaccharides (HMO).
Chapter 14 and 15, to describe Sialylated Human Milk Oligosaccharides (HMO) sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Sialylated Human Milk Oligosaccharides (HMO)
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 3'-Sialyllactose
    • 1.3.3 6'-Sialyllactose
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Infant Formula
    • 1.4.3 Food
    • 1.4.4 Others
  • 1.5 Global Sialylated Human Milk Oligosaccharides (HMO) Market Size & Forecast
    • 1.5.1 Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity (2019-2030)
    • 1.5.3 Global Sialylated Human Milk Oligosaccharides (HMO) Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Chr. Hansen (Jennewein Biotechnologie GmgH)
    • 2.1.1 Chr. Hansen (Jennewein Biotechnologie GmgH) Details
    • 2.1.2 Chr. Hansen (Jennewein Biotechnologie GmgH) Major Business
    • 2.1.3 Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Product and Services
    • 2.1.4 Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Chr. Hansen (Jennewein Biotechnologie GmgH) Recent Developments/Updates
  • 2.2 DSM (Glycom A/S)
    • 2.2.1 DSM (Glycom A/S) Details
    • 2.2.2 DSM (Glycom A/S) Major Business
    • 2.2.3 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product and Services
    • 2.2.4 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 DSM (Glycom A/S) Recent Developments/Updates
  • 2.3 Inbiose
    • 2.3.1 Inbiose Details
    • 2.3.2 Inbiose Major Business
    • 2.3.3 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product and Services
    • 2.3.4 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Inbiose Recent Developments/Updates
  • 2.4 Kyowa Hakko Bio
    • 2.4.1 Kyowa Hakko Bio Details
    • 2.4.2 Kyowa Hakko Bio Major Business
    • 2.4.3 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product and Services
    • 2.4.4 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Kyowa Hakko Bio Recent Developments/Updates
  • 2.5 GeneChem Inc.
    • 2.5.1 GeneChem Inc. Details
    • 2.5.2 GeneChem Inc. Major Business
    • 2.5.3 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product and Services
    • 2.5.4 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 GeneChem Inc. Recent Developments/Updates
  • 2.6 FrieslandCampina Ingredients
    • 2.6.1 FrieslandCampina Ingredients Details
    • 2.6.2 FrieslandCampina Ingredients Major Business
    • 2.6.3 FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Product and Services
    • 2.6.4 FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 FrieslandCampina Ingredients Recent Developments/Updates

3 Competitive Environment: Sialylated Human Milk Oligosaccharides (HMO) by Manufacturer

  • 3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Manufacturer (2019-2024)
  • 3.3 Global Sialylated Human Milk Oligosaccharides (HMO) Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Sialylated Human Milk Oligosaccharides (HMO) by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Sialylated Human Milk Oligosaccharides (HMO) Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Sialylated Human Milk Oligosaccharides (HMO) Manufacturer Market Share in 2023
  • 3.5 Sialylated Human Milk Oligosaccharides (HMO) Market: Overall Company Footprint Analysis
    • 3.5.1 Sialylated Human Milk Oligosaccharides (HMO) Market: Region Footprint
    • 3.5.2 Sialylated Human Milk Oligosaccharides (HMO) Market: Company Product Type Footprint
    • 3.5.3 Sialylated Human Milk Oligosaccharides (HMO) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Sialylated Human Milk Oligosaccharides (HMO) Market Size by Region
    • 4.1.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Region (2019-2030)
    • 4.1.3 Global Sialylated Human Milk Oligosaccharides (HMO) Average Price by Region (2019-2030)
  • 4.2 North America Sialylated Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030)
  • 4.3 Europe Sialylated Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030)
  • 4.5 South America Sialylated Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
  • 5.2 Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Type (2019-2030)
  • 5.3 Global Sialylated Human Milk Oligosaccharides (HMO) Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
  • 6.2 Global Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Application (2019-2030)
  • 6.3 Global Sialylated Human Milk Oligosaccharides (HMO) Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
  • 7.2 North America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
  • 7.3 North America Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country
    • 7.3.1 North America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
  • 8.2 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
  • 8.3 Europe Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country
    • 8.3.1 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Market Size by Region
    • 9.3.1 Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
  • 10.2 South America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
  • 10.3 South America Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country
    • 10.3.1 South America Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country
    • 11.3.1 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Sialylated Human Milk Oligosaccharides (HMO) Market Drivers
  • 12.2 Sialylated Human Milk Oligosaccharides (HMO) Market Restraints
  • 12.3 Sialylated Human Milk Oligosaccharides (HMO) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Sialylated Human Milk Oligosaccharides (HMO) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Sialylated Human Milk Oligosaccharides (HMO)
  • 13.3 Sialylated Human Milk Oligosaccharides (HMO) Production Process
  • 13.4 Sialylated Human Milk Oligosaccharides (HMO) Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Sialylated Human Milk Oligosaccharides (HMO) Typical Distributors
  • 14.3 Sialylated Human Milk Oligosaccharides (HMO) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Sialylated Human Milk Oligosaccharides (HMO). Industry analysis & Market Report on Sialylated Human Milk Oligosaccharides (HMO) is a syndicated market report, published as Global Sialylated Human Milk Oligosaccharides (HMO) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Sialylated Human Milk Oligosaccharides (HMO) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,773.56
    		4,160.34
    		5,547.12
    		3,236.40
    		4,854.60
    		6,472.80
    		532,022.40
    		798,033.60
    		1,064,044.80
    		290,336.40
    		435,504.60
    		580,672.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo